PBLS

Parabilis Medicines, Inc. Common Stock

26.84

USD

+0.33

+1.26%

Oct 28, 14:03 UTC -4

Open

Parabilis Medicines, Inc. Common Stock (PBLS) Profile

Parabilis Medicines, Inc. Common Stock Profile

About

Parabilis Medicines Inc. is a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the most consequential, yet historically undruggable, protein targets driving human disease. Parabilis Medicines Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Mathai Mammen

Headquarters

30 ACORN PARK DRIVE, 6TH FLOOR
CAMBRIDGE, MA 02140, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

145

Parabilis Medicines, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

3.32B

Enterprise Value

2.24B

Enterprise Value/EBITDA(ttm)

-22.98

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

-11309.97%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-23.46%

Return on Assets(ttm)

Income Statement

Revenue(ttm)

148.00K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

148.00K

EBITDA(ttm)³

-97.35M

Net Income Available to Common(ttm)

-137.83M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

52-Week Change

S&P 500 52-Week Change

19.97%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

123.53M

Dividend Yield

Float⁴

0.00

% Held by Insiders

% Held by Institutions

Balance Sheet

Total Cash(mrq)

1.12B

Total Cash Per Share(mrq)

9.07

Total Debt(mrq)

7.51M

Total Debt/Equity(mrq)

0.72%

Current Ratio(mrq)

17.91%

Quick Ratio(mrq)

Book Value Per Share(mrq)

8.48

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.83

Free Cash Flow(ytd)

-53.81M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.